Clinical Trial Update: Assessment of Gut Microbiota-Derived Amino Acid Metabolite Production in Patients With MASLD [NA]

View source ↗

Summary

A clinical trial from Hospices Civils de Lyon is assessing gut microbiota–derived amino acid metabolite production in patients with MASLD and MASH, and the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatohepatitis
• Metabolic Dysfunction-associated Steatotic Liver Disease

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction-Associated Steatohepatitis (MASH) | NA | Status: NOT_YET_RECRUITING